These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 18404150)

  • 1. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting.
    Winkles JA
    Nat Rev Drug Discov; 2008 May; 7(5):411-25. PubMed ID: 18404150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A further TWEAK to multiple sclerosis pathophysiology.
    Nazeri A; Heydarpour P; Sadaghiani S; Sahraian MA; Burkly LC; Bar-Or A
    Mol Neurobiol; 2014 Feb; 49(1):78-87. PubMed ID: 23873135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TWEAK/Fn14/CD163 axis-implications for metabolic disease.
    Ratajczak W; Atkinson SD; Kelly C
    Rev Endocr Metab Disord; 2022 Jun; 23(3):449-462. PubMed ID: 34542797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in rheumatic diseases.
    Zhu LX; Zhang HH; Mei YF; Zhao YP; Zhang ZY
    Chin Med J (Engl); 2012 Nov; 125(21):3898-904. PubMed ID: 23106895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
    Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
    Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
    Brown SA; Cheng E; Williams MS; Winkles JA
    PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-κB pathway.
    Zhu C; Zhang L; Liu Z; Li C; Bai Y
    J Cell Biochem; 2018 Apr; 119(4):3528-3536. PubMed ID: 29143982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the TWEAK/Fn14 pathway in autoimmune diseases.
    Xu WD; Zhao Y; Liu Y
    Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TWEAK-Fn14 system as a potential drug target.
    Wajant H
    Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
    Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
    Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Necrosis Factor Receptor Mediates Fibroblast Growth Factor-Inducible 14 Signaling.
    Wang X; Xiao S; Xia Y
    Cell Physiol Biochem; 2017; 43(2):579-588. PubMed ID: 28934756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TWEAK/Fn14 signaling in tumors.
    Hu G; Zeng W; Xia Y
    Tumour Biol; 2017 Jun; 39(6):1010428317714624. PubMed ID: 28639899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges.
    Méndez-Barbero N; Gutiérrez-Muñoz C; Blázquez-Serra R; Martín-Ventura JL; Blanco-Colio LM
    Cells; 2020 Feb; 9(2):. PubMed ID: 32053869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.
    Polek TC; Talpaz M; Darnay BG; Spivak-Kroizman T
    J Biol Chem; 2003 Aug; 278(34):32317-23. PubMed ID: 12794080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion.
    Cheng E; Whitsett TG; Tran NL; Winkles JA
    Mol Cancer Res; 2015 Mar; 13(3):575-83. PubMed ID: 25392346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease.
    Gomez IG; Roach AM; Nakagawa N; Amatucci A; Johnson BG; Dunn K; Kelly MC; Karaca G; Zheng TS; Szak S; Peppiatt-Wildman CM; Burkly LC; Duffield JS
    J Am Soc Nephrol; 2016 Dec; 27(12):3639-3652. PubMed ID: 27026366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TWEAK/Fn14 Activation Participates in Skin Inflammation.
    Liu Q; Xiao S; Xia Y
    Mediators Inflamm; 2017; 2017():6746870. PubMed ID: 29038621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.
    Wiley SR; Winkles JA
    Cytokine Growth Factor Rev; 2003; 14(3-4):241-9. PubMed ID: 12787562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease.
    Tajrishi MM; Zheng TS; Burkly LC; Kumar A
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):215-25. PubMed ID: 24444596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.